Phase Ib Trial of Folate Binding Protein (FBP)-Derived Peptide Vaccines, E39 and an Attenuated Version, E39′: An Analysis of Safety and immune Response

In this randomized phase Ib trial, we tested combining the E39 peptide vaccine with a vaccine created from E39′, an attenuated version of E39. Patients with breast or ovarian cancer, who were disease-free after standard of care therapy, were enrolled and randomized to one of three arms. Arm EE recei...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Immunol
Hauptverfasser: Vreeland, Timothy J., Litton, Jennifer K., Qiao, Na, Philips, Anne V., Alatrash, Gheath, Hale, Diane F., Jackson, Doreen O., Peace, Kaitlin M., Greene, Julia M., Berry, John S, Clifton, Guy T., Peoples, George E
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2018
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5988975/
https://ncbi.nlm.nih.gov/pubmed/29574039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2018.03.010
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge